Background: With advances in antiretroviral therapy, most deaths in people with HIV are
now attributable to noncommunicable illnesses, especially cardiovascular disease. We …

According to statistics from the World Health Organization,≈ 36.7 million people are
currently living with HIV, and 1.8 million become infected every year. Antiretroviral therapy …

Background People living with HIV (PLWH) experience higher risk of myocardial infarction
(MI) and heart failure (HF) compared with uninfected individuals. Risk of other …

Abstract Background Sub-Saharan Africa (SSA) has confronted decades of the HIV
epidemic with substantial improvements in access to life-saving antiretroviral therapy (ART) …

As early and effective antiretroviral therapy has become more widespread, HIV has
transitioned from a progressive, fatal disease to a chronic, manageable disease marked by …

HIV-related cardiovascular disease research is predominantly from Europe and North
America. Of the estimated 37· 9 million people living with HIV worldwide, 25· 6 million live in …

Objectives The aim of this study was to estimate the relative risk of cardiovascular disease
(CVD) among people living with HIV (PLHIV) compared with the HIV‐uninfected population …

Widespread use of contemporary antiretroviral therapy globally has transformed HIV
disease into a chronic illness associated with excess risk for disorders of the heart and …

Background In the 2000s, adults with HIV had a higher risk for atherosclerotic cardiovascular
disease (ASCVD) compared with those without HIV. There is uncertainty if this excess risk …

Objective Cardiovascular disease (CVD) is one of the leading non-AIDS-defining causes of
death among HIV-positive (HIV+) individuals. However, the evidence surrounding specific …